share_log
Reuters ·  Apr 28 19:34
Celltrion USA Signs Agreement With Express Scripts for Its Therapy for Autoimmune Diseases Including the First FDA-Approved Subcutaneous Infliximab Zymfentra™
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment